Medesis Pharma SA (ALMDP) — Net Asset Quality Index
Medesis Pharma SA (ALMDP) has a Net Asset Quality Index of -242.0% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.11 Million minus total liabilities of €7.20 Million yields net assets of €-5.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore ALMDP debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Medesis Pharma SA Net Asset Quality Index Over Time (2018–2023)
This chart shows how Medesis Pharma SA's Net Asset Quality Index has evolved across 6 annual periods from 2018 to 2023. As of June 2024, the index stands at -242.0%, representing net assets of €-5.10 Million against total assets of €2.11 Million EUR. See what is Medesis Pharma SA's book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Medesis Pharma SA (2018–2023)
The table below presents the year-by-year Net Asset Quality Index for Medesis Pharma SA from 2018 to 2023, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ALMDP market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | -233.6% | €-4.50 Million | €1.93 Million | €6.43 Million | ▼ -178.4 pp |
| 2022 | -55.2% | €-1.06 Million | €1.92 Million | €2.97 Million | ▼ -93.3 pp |
| 2021 | 38.0% | €1.65 Million | €4.33 Million | €2.68 Million | ▲ +286.6 pp |
| 2020 | -248.6% | €-2.08 Million | €837.91K | €2.92 Million | ▲ +90.1 pp |
| 2019 | -338.7% | €-2.42 Million | €714.00K | €3.13 Million | ▼ -284.7 pp |
| 2018 | -53.9% | €-876.00K | €1.62 Million | €2.50 Million | — |